Ilaria Avonto

Statistics

Publications

Citations

1.3K

H-Index

Active since

2005

Affiliations

Azienda Ospedaliero Universitaria San Giovanni Battista(Current)

St. Eugenio Hospital

Fondazione Gimema Onlus

Casa Sollievo della Sofferenza

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo

Ilaria Avonto is an author at Azienda Ospedaliero Universitaria San Giovanni Battista specializing in medicine, chemotherapy, and hematologic oncology.

Publications per year

2005–2022

Publications

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Antonio Palumbo, Tommaso Caravita, Emanuela Merla et al. · The Lancet · 2006 · 808 citations

Medicine, Oncology, Pharmacology +17

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo et al. · Blood · 2006 · 181 citations · Full text

Medicine, Hematology, Oncology +12

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma

Antonio Palumbo, Francesca Gay, Sara Bringhen et al. · Annals of Oncology · 2008 · 127 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma

Antonio Palumbo, Ilaria Avonto, Benedetto Bruno et al. · European Journal Of Haematology · 2006 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +15

Thalidomide–dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide–dexamethasone: a case‐matched study in advanced multiple myeloma

Massimo Offidani, Laura Corvatta, Patrizia Falco et al. · European Journal Of Haematology · 2007 · 30 citations

Medicine, Hematology, Oncology +16

1–5 of 13